SURVEY deadline extended – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist,

You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic anti-cancer therapy (SACT). We hope to learn which factors (such as perceived usefulness, ease of use, social influence, supporting resources, enjoyment, perceived value and habits) are most important in shaping pharmacists’ engagement with ChemoCare EPS. The findings from this study may help inform strategies for the effective implementation, adoption, and ongoing development of ChemoCare and similar EPSs.

Time required: -15-20 minutes

Consent and survey Link: https://forms.office.com/Pages/ResponsePage.aspx?id=z8oksN7eQUKhXDyX1VPp80BNOFX5nBZEigFaU-yegcBUOUNQQkhZRk84SFAwVDRRNkJVVVBRSjUwUS4u

Deadline extended: 11th July 2025

The survey has been approved by the University of Birmingham ethics committee.  It is also supported by the organisation BOPA, that has kindly agreed to distribute the survey.  This research is not funded by ChemoCare or any other organisation.

Thank you sincerely for your time and contribution!

Regards, Elida Mudaly